List of Excipients in API apixaban
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing apixaban
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ER Squibb & Sons LLC | ELIQUIS | apixaban | 0003-0893 | ANHYDROUS LACTOSE | |
| ER Squibb & Sons LLC | ELIQUIS | apixaban | 0003-0893 | CELLULOSE, MICROCRYSTALLINE | |
| ER Squibb & Sons LLC | ELIQUIS | apixaban | 0003-0893 | CROSCARMELLOSE SODIUM | |
| ER Squibb & Sons LLC | ELIQUIS | apixaban | 0003-0893 | FERRIC OXIDE YELLOW | |
| ER Squibb & Sons LLC | ELIQUIS | apixaban | 0003-0893 | HYPROMELLOSE | |
| ER Squibb & Sons LLC | ELIQUIS | apixaban | 0003-0893 | LACTOSE MONOHYDRATE | |
| ER Squibb & Sons LLC | ELIQUIS | apixaban | 0003-0893 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing apixaban
Detailed excipient profiles for apixaban
Excipient focus: ANHYDROUS LACTOSE
apixaban drug variants containing ANHYDROUS LACTOSE
apixaban drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
apixaban drug variants containing CELLULOSE, MICROCRYSTALLINE
apixaban drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
apixaban drug variants containing CROSCARMELLOSE SODIUM
apixaban drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
apixaban drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | apixaban | 50090-6454 |
| Bryant Ranch Prepack | apixaban | 63629-7747 |
| RedPharm Drug Inc | apixaban | 67296-1673 |
| REMEDYREPACK INC | apixaban | 70518-1861 |
| Aphena Pharma Solutions - Tennessee LLC | apixaban | 71610-662 |
| Proficient Rx LP | apixaban | 82804-085 |
| Pharmasource Meds LLC | apixaban | 82982-054 |
| >Company | >Ingredient | >NDC |
apixaban drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
apixaban drug variants containing FERRIC OXIDE YELLOW
apixaban drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | apixaban | 50090-6454 |
| Bryant Ranch Prepack | apixaban | 63629-7747 |
| RedPharm Drug Inc | apixaban | 67296-1673 |
| REMEDYREPACK INC | apixaban | 70518-1861 |
| Aphena Pharma Solutions - Tennessee LLC | apixaban | 71610-662 |
| Proficient Rx LP | apixaban | 82804-085 |
| Pharmasource Meds LLC | apixaban | 82982-054 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
apixaban drug variants containing HYPROMELLOSE
apixaban drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
apixaban drug variants containing LACTOSE MONOHYDRATE
apixaban drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
apixaban drug variants containing MAGNESIUM STEARATE
apixaban drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
apixaban drug variants containing SODIUM LAURYL SULFATE
apixaban drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
apixaban drug variants containing TITANIUM DIOXIDE
apixaban drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
apixaban drug variants containing TRIACETIN
apixaban drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
